Jefferies Group LLC Athenex, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $121,854 - $245,251	-154,246 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $209,774 - $453,483	154,246 New	154,246 $80,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $331,800 - $420,300	-30,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $307,800 - $436,500	30,000 New	30,000 $363,000
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $149,881 - $416,046	-26,249 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$9.6 - $17.75 $86,150 - $159,288	8,974 Added 51.95%	26,249 $401,000
Q3 2019 Nov 13, 2019	BUY	$12.16 - $21.0 $210,064 - $362,775	17,275 New	17,275 $210,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.